Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Hospitals are driving up healthcare costs

The growth in hospital prices is driving up healthcare costs for private insurance more than the rise in physician prices, according to a recent study in Health Affairs.

Thumbnail

Baylor Scott & White, Memorial Hermann won’t merge

After signing a letter of intent to explore a merger in October 2018, Baylor Scott & White Health and Memorial Hermann Health System have dissolved the plan.

Thumbnail

Industry support gathers for expanding MA benefits in 2020

Since CMS proposed expanding supplemental benefits for Medicare Advantage for the 2020 plan year, several industry groups have voiced their support, seeing opportunities to improve care for individuals with chronic illnesses and lower costs.

Thumbnail

HHS proposal tackles drug rebates

HHS has proposed lowering drug costs by targeting the rebate system, which has recently come under scrutiny as an opaque setup that keeps drug prices high.

Thumbnail

Zuckerberg Hospital pauses balance billing practice after media reports

Zuckerberg San Francisco General Hospital has temporarily halted its “aggressive” billing practices after media reports brought backlash against the trauma center named after Facebook founder and CEO Mark Zuckerberg, the San Francisco Chronicle reported.

Thumbnail

CHI and Dignity complete merger, renamed CommonSpirit

Catholic Health Initiatives (CHI) and Dignity Health have completed their merger, launching a new nonprofit Catholic health system, CommonSpirit Health. The deal brings together two of the nation’s largest Catholic healthcare systems.

Thumbnail

HCA completes $1.5B acquisition of Mission Health

Nashville-based HCA Healthcare completed its purchase of Mission Health for approximately $1.5 billion.

Human insulin therapy minimizes out-of-pocket costs for type 2 diabetics

Switching type 2 diabetics from analogue insulin therapies to human insulin products saves patients money without compromising health, according to new research published in JAMA.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.